R. Medicus

发表

(complement activation/initiating factor/properdin activation/properdin receptor/multisubunit enzymes)

R. Schreiber, O. Götze, H. Müller-Eberhard, 2016 .

Infection of immune mast cells by Harvey sarcoma virus: immortalization without loss of requirement for interleukin-3

J. Ihle, J. Keller, A. Schultz, 1985, Molecular and cellular biology.

A novel way of relating the structure of Cl1 to the hemolytic activity of the first component of complement.

T. Borsós, R. Medicus, H. Isliker, 1980, Molecular immunology.

Fructose-1, 6-diphosphatase, phosphofructokinase, glycogen synthetase, phosphorylase, and protein kinase from swine kidney.

N. Kratowich, J. Mendicino, R. Medicus, 1975, Methods in enzymology.

Role of enzyme interactions in the regulation of glycolysis and gluconeogenesis. Purification and properties of the phospho- and dephospho-forms of glycogen phosphorylase from swine kidney.

J. Mendicino, R. Medicus, 1973, European journal of biochemistry.

Fractionation of of proteolytic enzymes by affinity chromatography on sepharose aminocaproyl proflavin.

R. Medicus, R. McRORIE, J. H. Brantner, 1976, Journal of chromatography.

Potentiation of antiboty-dependent cell-mediated cytotoxicity by target cell-bound C3b.

H. Müller-Eberhard, R. Medicus, B. Ghebrehiwet, 1979, Journal of immunology.

Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor

R. Schreiber, H. Müller-Eberhard, R. Medicus, 1975, The Journal of experimental medicine.

A molecular concept of the properdin pathway.

R. Schreiber, O. Götze, H. Müller-Eberhard, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor.

H. Colten, M. Arnaout, R. Medicus, 1983, Immunology.

Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway

O. Götze, H. Müller-Eberhard, R. Medicus, 1976, The Journal of experimental medicine.

Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1980, Clinical immunology and immunopathology.

Release of C3c from bound C3bi by C3b inactivator

M. Arnaout, R. Medicus, 1982 .

Native and activated properdin: interconvertibility and identity of amino- and carboxy-terminal sequences.

H. Müller-Eberhard, R. Medicus, A. F. Esser, 1980, Journal of immunology.

The first component of complement. I. Purification and properties of native C1.

R. Medicus, R. Chapuis, 1980, Journal of immunology.

The Serine Protease Nature of the C3 and C5 Convertases of the Classical and Alternative Complement Pathways

O. Götze, H. Müller-Eberhard, R. Medicus, 1976, Scandinavian journal of immunology.

Biochemical and Biological Properties of Interleukin-3

R. Mural, J. Ihle, J. Keller, 1984 .

Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.

H. Colten, M. Arnaout, R. Medicus, 1983, Journal of immunology.

Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin.

O. Götze, H. Müller-Eberhard, R. Medicus, 1977, Journal of immunology.

Role of human factor I and C3b receptor in the cleavage of surface‐bound C3bi molecules

M. Arnaout, R. Medicus, J. Melamed, 1983, European journal of immunology.

Mast Cells Induced in Vitro by Interleukin 3 from Native Murine Thymus Cells

H. Kawanishi, R. Medicus, E. Palaszynski, 1986, Scandinavian journal of immunology.